Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.

Viruses - 18 May 2020

Ji Hezhao, Parkin Neil, Gao Feng, Denny Thomas, Jennings Cheryl, Sandstrom Paul, Kantor Rami

Abstract excerpt

Next-generation sequencing (NGS) is likely to become the new standard method for HIV drug resistance (HIVDR) genotyping. Despite the significant advances in the development of wet-lab protocols and bioinformatic data processing pipelines, one often-missing critical component of an NGS HIVDR assay for clinical use is external quality assessment (EQA). EQA is essential for ensuring assay consistency and laboratory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congresses as Topic
Share to Diagnostic Tests, Routine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to High-Throughput Nucleotide Sequencing

Share to HIV Infections

Share to Quality Assurance, Health Care

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 32443529
DOI: 10.3390/v12050556
PMCID: PMC7291315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.PMID 32443529Read ↗

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Semantic proximity Read ↗

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.Semantic proximity Read ↗

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.Semantic proximity Read ↗

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Semantic proximity Read ↗

Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg ConsensusSemantic proximity Read ↗

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” SymposiumSemantic proximity Read ↗

External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand.Semantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

Next Generation Sequencing Based In-house HIV Genotyping Method: Validation ReportSemantic proximity Read ↗

External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European LaboratoriesSemantic proximity Read ↗

Deep sequencing for HIV-1 clinical management.Semantic proximity Read ↗

External Quality Assessment for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Clinical LaboratoriesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.